Third, while GM-CSF/G-CSF were found to be valuable for ACLF patients and COVID-19 patients, they had not been recommended by Chinese guidelines during the subject inclusion; as a result, we did not observe the efficacy of GM-CSF/G-CSF treatment. This evidence concerns the gene CSF2 and COVID-19.